{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "exchange": "NMS", "regularMarketChangePercent": 2.0408175, "regularMarketPrice": 15.0, "firstTradeDateMilliseconds": 1651843800000, "priceHint": 2, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -4.66, "epsForward": -3.33, "epsCurrentYear": -3.32, "priceEpsCurrentYear": -4.5180726, "sharesOutstanding": 23782300, "bookValue": 7.575, "fiftyDayAverage": 13.7818, "fiftyDayAverageChange": 1.2181997, "fiftyDayAverageChangePercent": 0.088391915, "twoHundredDayAverage": 12.96155, "twoHundredDayAverageChange": 2.0384502, "twoHundredDayAverageChangePercent": 0.15726902, "marketCap": 356734496, "forwardPE": -4.5045047, "priceToBook": 1.980198, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "shortName": "PepGen Inc.", "longName": "PepGen Inc.", "messageBoardId": "finmb_1677986244", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.3000002, "regularMarketTime": 1684180805, "regularMarketDayHigh": 15.35, "regularMarketDayRange": "14.5967 - 15.35", "regularMarketDayLow": 14.5967, "regularMarketVolume": 51750, "regularMarketPreviousClose": 14.7, "bid": 0.0, "ask": 0.0, "bidSize": 8, "askSize": 8, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 14.77, "averageDailyVolume3Month": 36075, "averageDailyVolume10Day": 33780, "fiftyTwoWeekLowChange": 10.68, "fiftyTwoWeekLowChangePercent": 2.472222, "fiftyTwoWeekRange": "4.32 - 20.0", "fiftyTwoWeekHighChange": -5.0, "fiftyTwoWeekHighChangePercent": -0.25, "fiftyTwoWeekLow": 4.32, "fiftyTwoWeekHigh": 20.0, "displayName": "PepGen", "symbol": "PEPG"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "321 Harrison Avenue", "address2": "8th Floor", "city": "Boston", "state": "MA", "zip": "02118", "country": "United States", "phone": "(781) 797-0979", "website": "https://pepgen.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that id in Phase I clinical trial to treat individuals with Duchenne muscular dystrophy (DMD). The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 45, "companyOfficers": [{"maxAge": 1, "name": "Dr. James G. McArthur Ph.D.", "age": 60, "title": "Pres, CEO, Treasurer, Sec. & Director", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 834983, "fmt": "834.98k", "longFmt": "834,983"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 2396032, "fmt": "2.4M", "longFmt": "2,396,032"}}, {"maxAge": 1, "name": "Mr. Noel P. Donnelly M.B.A.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 650170, "fmt": "650.17k", "longFmt": "650,170"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 147672, "fmt": "147.67k", "longFmt": "147,672"}}, {"maxAge": 1, "name": "Mr. Niels  Svenstrup Ph.D.", "age": 52, "title": "Sr. VP of Chemistry, Manufacturing & Control", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 455150, "fmt": "455.15k", "longFmt": "455,150"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 168610, "fmt": "168.61k", "longFmt": "168,610"}}, {"maxAge": 1, "name": "Ms. Caroline  Godfrey Ph.D.", "title": "Founder & Scientific Advisory Board Member", "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael  Gait", "title": "Founder & Scientific Advisory Board Member", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sonia  Bracegirdle DPHIL", "age": 36, "title": "Sr. VP of Strategy & Operations", "yearBorn": 1986, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jaya  Goyal Ph.D.", "age": 54, "title": "Exec. VP of Research & Preclinical Devel.", "yearBorn": 1968, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jennifer  Cormier", "title": "Sr. VP of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michelle L. Mellion M.D.", "age": 46, "title": "Sr. VP & Head of Clinical Devel.", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kyle  Breidenstine", "title": "VP of Fin. & Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}